ABVC BioPharma, Inc. Unrealized Gain (Loss) on Investments
ABVC BioPharma, Inc. (ABVC) reported Unrealized Gain (Loss) on Investments of -$269.84 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2023-03-31
- ABVC BioPharma, Inc. unrealized gain (loss) on investments for the quarter ending 2021-12-31 was -$76.70K.
- ABVC BioPharma, Inc. unrealized gain (loss) on investments for the quarter ending 2021-09-30 was -$91.77K.
- ABVC BioPharma, Inc. unrealized gain (loss) on investments for the quarter ending 2021-06-30 was -$53.59K.
- ABVC BioPharma, Inc. unrealized gain (loss) on investments for the quarter ending 2021-03-31 was -$47.79K.
- ABVC BioPharma, Inc. unrealized gain (loss) on investments for fiscal 2021 was -$269.84K.
- ABVC BioPharma, Inc. unrealized gain (loss) on investments for fiscal 2020 was -$1.17M.
- ABVC BioPharma, Inc. unrealized gain (loss) on investments for fiscal 2019 was -$210.09K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$76.70K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$168.46K derived: sum of 2 quarters · filed 2023-03-31 | -$222.05K derived: sum of 3 quarters · filed 2023-03-31 | -$269.84K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$91.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$145.36K derived: sum of 2 quarters · filed 2022-11-14 | -$193.15K 10-Q · filed 2022-11-14 | -$294.58K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$53.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$101.38K 10-Q · filed 2022-08-15 | -$202.82K derived: sum of 3 quarters · filed 2022-08-15 | -$1.09M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$47.79K 10-Q · filed 2022-05-16 | -$149.23K derived: sum of 2 quarters · filed 2022-05-16 | -$1.04M derived: sum of 3 quarters · filed 2022-05-16 | -$1.15M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$101.44K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$988.67K derived: sum of 2 quarters · filed 2022-03-31 | -$1.10M derived: sum of 3 quarters · filed 2022-03-31 | -$1.17M 10-K · filed 2022-03-31 |
| 2020-09-30 | -$887.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$996.89K derived: sum of 2 quarters · filed 2021-11-15 | -$1.07M 10-Q · filed 2021-11-15 | -$1.10M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$109.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$180.07K 10-Q · filed 2021-08-12 | -$208.04K derived: sum of 3 quarters · filed 2021-08-12 | -$272.73K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$70.41K 10-Q · filed 2021-05-10 | -$98.38K derived: sum of 2 quarters · filed 2021-05-10 | -$163.07K derived: sum of 3 quarters · filed 2021-05-10 | -$214.29K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | -$27.97K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$92.66K derived: sum of 2 quarters · filed 2021-03-16 | -$143.88K derived: sum of 3 quarters · filed 2021-03-16 | -$210.09K 10-K · filed 2021-03-16 |
| 2019-09-30 | -$64.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-17 | -$115.91K derived: sum of 2 quarters · filed 2020-11-17 | -$182.11K 10-Q · filed 2020-11-17 | |
| 2019-06-30 | -$51.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$117.42K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | -$66.20K 10-Q · filed 2020-06-29 |